PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för SN-38 carboxylate. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

10 hits

Bibliografisk träff 2020-03-17

Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients.

Karas S, Etheridge AS, Tsakalozou E, Ramírez J, Cecchin E, van Schaik RHN, Toffoli G, Ratain MJ, Mathijssen RHJ, Forrest A, Bies RR, Innocenti F.

AAPS J · journal article · DOI 10.1208/s12248-020-0429-4

Bibliografisk träff 2012-01-01

Involvement of specific transport system on uptake of lactone form of SN-38 in human intestinal epithelial cell line Caco-2.

Ueno Y, Matsuda H, Mizutani H, Iwamoto T, Okuda M.

Biol Pharm Bull · research support, non-u.s. gov't; journal article · DOI 10.1248/bpb.35.54

Bibliografisk träff 2007-05-30

Involvement of up-regulation of hepatic breast cancer resistance protein in decreased plasma concentration of 7-ethyl-10-hydroxycamptothecin (SN-38) by coadministration of S-1 in rats.

Yokoo K, Hamada A, Watanabe H, Matsuzaki T, Imai T, Fujimoto H, Masa K, Imai T, Saito H.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.107.015164

Bibliografisk träff 2005-11-01

Human multidrug resistance associated protein 4 confers resistance to camptothecins.

Tian Q, Zhang J, Tan TM, Chan E, Duan W, Chan SY, Boelsterli UA, Ho PC, Yang H, Bian JS, Huang M, Zhu YZ, Xiong W, Li X, Zhou S.

Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s11095-005-7595-z

Bibliografisk träff 2005-07-01

Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat.

Yang X, Hu Z, Chan SY, Goh BC, Duan W, Chan E, Zhou S.

J Chromatogr B Analyt Technol Biomed Life Sci · research support, non-u.s. gov't; validation study; journal article · DOI 10.1016/j.jchromb.2005.05.010

Bibliografisk träff 2003-06-01

Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats.

Arimori K, Kuroki N, Hidaka M, Iwakiri T, Yamsaki K, Okumura M, Ono H, Takamura N, Kikuchi M, Nakano M.

Pharm Res · journal article · DOI 10.1023/a:1023847521767

Bibliografisk träff 2002-02-01

Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study.

van Riel JM, van Groeningen CJ, Kedde MA, Gall H, Leisink JM, Gruia G, Pinedo HM, van der Vijgh WJ, Giaccone G.

Clin Cancer Res · clinical trial; clinical trial, phase i; journal article

Bibliografisk träff 2002-01-01

Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea.

Ikegami T, Ha L, Arimori K, Latham P, Kobayashi K, Ceryak S, Matsuzaki Y, Bouscarel B.

Cancer Res · research support, non-u.s. gov't; journal article

Bibliografisk träff 1997-08-01

The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms.

Haaz MC, Rivory LP, Riché C, Robert J.

Naunyn Schmiedebergs Arch Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1007/pl00005049

Bibliografisk träff 1997-04-01

Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.

Chu XY, Kato Y, Niinuma K, Sudo KI, Hakusui H, Sugiyama Y.

J Pharmacol Exp Ther · research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-3565(24)36601-7